Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

+44-7482878454

Citations Report

Citations Report - Mycobacterial Diseases [315 Articles]

The articles published in Mycobacterial Diseases have been cited 315 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Mycobacterial Diseases.

Pennington KM, Kennedy CC, Chandra S, Lauzardo M, Brito MO, Griffith DE, et al. Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review. J Clin Tuberculosis and Other Mycobact Dis. 2018:11;37-46.

Dash M. Microbiology: An International Journal. 2016.

Ramos GP, Stroh G, Al-Bawardy B, Faubion WA, Papadakis KA, Escalante P. Outcomes of treatment for latent tuberculosis infection in patients with inflammatory bowel disease receiving biologic therapy. Inflammatory Bowel Dis. 2018:24(10);2272-2277.

Dash M. Microbiology: An International Journal. 2016.

Sintra SN, Madaleno J, Canha C, Simão A, Carvalho A. Liver scalloping–An unusual presentation of a benign. Int J Case Rep Images. 2019;10:101001Z01SS2019.

Serman F, Saavedra M, Feldman R, Concha C, Vitar C, Bustos A, et al. Tuberculosis peritoneal con presentación clínica como cáncer ovárico avanzado: revisión de la literatura. Revista chilena de obstetricia y ginecología. 2016:81(5);411-420.

Ngonge AL, Ekaney DS, Sama CB, Musonge-Effoe J, Effoe VS, Ekwen G. Multiple jejunal perforation secondary to intestinal tuberculosis infection: a case report. The Pan African Med J. 2017:27.

Srivastava G, Tiwari A, Sharma A. Computational Methods for Multi-Target Drug Designing Against Mycobacterium tuberculosis. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. 2019:459-483.

Srivastava G, Tiwari A, Sharma A. Computational Methods for Multi-Target Drug Designing Against Mycobacterium tuberculosis. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. 2019:459-483.

Quiros SM. Design, synthesis and evaluation of new nanosystems for application in biomedicine. Complutense University of Madrid. 2018.

Reis AJ, Diniz JL, Silva AB, Silveira J, Basso R, Vieira R, et al. Laboratory tools for tuberculosis control in a setting with a high burden of HIV/AIDS. Journal of medical microbiology. 2019:68(11);1622-1628.

Sabbineni J. Research and Reviews: Journal of Hospital and Clinical Pharmacy.

Dash M. Microbiology: An International Journal. 2016.

Chikhale RV, Barmade MA, Murumkar PR, Yadav MR. Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis. J Med Chem. 2018:61(19);8563-8593.

Uddin R, Siddiqui QN, Sufian M, Azam SS, Wadood A. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target. Genes & genomics. 2019:41(11);1281-1292.

Dash M. Microbiology: An International Journal. 2016.

Banumathi V. A REVIEW ON SIDDHA HERBAL FORMULATION DEVA CHOORANAM FOR IMPROVING THE QOL IN ACQUIRED IMMUNO DEFICIENCY SYNDROME (AIDS). 2017.

Gupta AK, Singh A, Singh S. Glycogen as key energy storehouse and possibly responsible for multidrug resistance in Mycobacterium tuberculosis. InDrug Resistance in Bacteria, Fungi, Malaria, and Cancer 2017:263-285.

Ukibe NR, Ndiuwem CK, Ogbu II, Ukibe SN, Ehiaghe FA, Ikimi CG. Prognostic value of some serum protein fractions as Early Index of Clinical Recovery in Pulmonary Tuberculosis subjects. Indian J Tuberculosis. 2019.

Bhattacharyya SK, Howlader S, Thakur SB. STUDY OF SERUM PROTEIN, ALBUMIN, GLOBULIN AND ALBUMIN/GLOBULIN RATIO IN RELATION WITH HIV PATIENTS. J Evol Med Dental Sci. 2018:7(37);4918-4921.

Relevant Topics

Top